James Thompson

4.6k total citations · 1 hit paper
77 papers, 2.9k citations indexed

About

James Thompson is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, James Thompson has authored 77 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Pulmonary and Respiratory Medicine, 18 papers in Rheumatology and 18 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in James Thompson's work include Prostate Cancer Diagnosis and Treatment (39 papers), Prostate Cancer Treatment and Research (28 papers) and Urologic and reproductive health conditions (16 papers). James Thompson is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (39 papers), Prostate Cancer Treatment and Research (28 papers) and Urologic and reproductive health conditions (16 papers). James Thompson collaborates with scholars based in Australia, Netherlands and United States. James Thompson's co-authors include Phillip D. Stricker, Warick Delprado, Maret Böhm, Anne‐Maree Haynes, Ron Shnier, Matthijs J. Scheltema, Daniel Moses, Phillip Brenner, Pim J. van Leeuwen and Andrew Hayen and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

James Thompson

75 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

2015 282 citations James Thompson et al. profile →

Peers

Countries citing papers authored by James Thompson

Since Specialization

Citations

This map shows the geographic impact of James Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Thompson more than expected).

Fields of papers citing papers by James Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Thompson. The network helps show where James Thompson may publish in the future.

Co-authorship network of co-authors of James Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of James Thompson. A scholar is included among the top collaborators of James Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Thompson. James Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti‐tumour T‐cell activation – IRE ‐ IMMUNO study 2024 ·British Journal of Urology ·Bart Geboers, Matthijs J. Scheltema, Jason J. Jung, (unknown), Florentine E. F. Timmer, (unknown), (unknown), (unknown), (unknown), (unknown), Shikha Agrawal, Jayne Matthews, Anne‐Maree Haynes, (unknown), James Thompson, Martijn R. Meijerink, Susan J. Clark, Tanja D. de Gruijl, Phillip D. Stricker	4
2	Index grade group is superior to composite grade group for prediction of biochemical recurrence following radical prostatectomy 2023 ·Pathology ·(unknown), (unknown), Zhixin Liu, (unknown), Anne‐Maree Haynes, Warick Delprado, Fiona Maclean, Carlo Yuen, Phillip D. Stricker, James Thompson	3
3	The relationship between biochemical recurrence and number of lymph nodes removed during surgery for localized prostate cancer 2023 ·BMC Urology ·(unknown), (unknown), Matthijs J. Scheltema, Andrew Hayen, Amer Amin, Amila Siriwardana, (unknown), Bart Geboers, (unknown), (unknown), Jayne A. Matthews, Warick Delprado, Phillip D. Stricker, James Thompson	1
4	A Novel Risk Calculator Incorporating Clinical Parameters, Multiparametric Magnetic Resonance Imaging, and Prostate-Specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Risk Stratification Before Transperineal Prostate Biopsy 2023 ·European Urology Open Science ·B.D. Kelly, (unknown), Matthew J. Roberts, (unknown), Phillip D. Stricker, James Thompson, James P Buteau, Kenneth Chen, Omar Alghazo, J O’Brien, Michael S. Hofman, Mark Frydenberg, Nathan Lawrentschuk, Dara Lundon, Declan G. Murphy, Louise Emmett, Daniel Moon	8
5	The PRIMARY Score: Using intra-prostatic PSMA PET/CT patterns to optimise prostate cancer diagnosis. 2022 ·Journal of Nuclear Medicine ·Louise Emmett, Nathan Papa, James P Buteau, Bao Ho, Victor Liu, Matthew J. Roberts, James Thompson, Daniel Moon, Gemma Sheehan‐Dare, Omar Alghazo, Shikha Agrawal, Declan G. Murphy, Phillip D. Stricker, Thomas A. Hope, Michael S. Hofman	68
6	High prostate‐specific membrane antigen ( PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI‐RADS score 4 or 5 confers a high probability of significant prostate cancer 2022 ·British Journal of Urology ·(unknown), Nathan Papa, B.D. Kelly, James Thompson, Phillip D. Stricker, Matthew J. Roberts, Michael S. Hofman, James P Buteau, Declan G. Murphy, Louise Emmett, Daniel Moon	11
7	Synchronous vs independent reading of prostate‐specific membrane antigen positron emission tomography ( PSMA‐PET) and magnetic resonance imaging ( MRI) to improve diagnosis of prostate cancer 2022 ·British Journal of Urology ·(unknown), (unknown), Nathan Papa, Gemma Sheehan‐Dare, Bao Ho, Jonathan Lee, Victor Liu, James Thompson, Shikha Agrawal, Matthew J. Roberts, James P Buteau, Michael S. Hofman, Daniel Moon, Nathan Lawrentschuk, Declan G. Murphy, Phillip D. Stricker, Louise Emmett	4
8	Salvage robot-assisted radical prostatectomy following focal ablation with irreversible electroporation: feasibility, oncological and functional outcomes 2022 ·BMC Urology ·Alexandar Blazevski, (unknown), Matthijs J. Scheltema, Amer Amin, Bart Geboers, (unknown), Anne‐Maree Haynes, Ron Shnier, Warick Delprado, Shikha Agrawal, James Thompson, Phillip D. Stricker	9
9	Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging to Detect Residual Prostate Cancer Following Irreversible Electroporation—A Multicenter Validation Study 2022 ·European Urology Focus ·Bart Geboers, (unknown), James Thompson, (unknown), (unknown), David Zhang, Alexandar Blazevski, (unknown), Shikha Agrawal, Jayne Matthews, Anne‐Maree Haynes, Zhixin Liu, (unknown), Ron Shnier, Theo M. de Reijke, Nathan Lawrentschuk, (unknown), John Yaxley, Matthijs J. Scheltema, Phillip D. Stricker	14
10	Urine exosomes as biomarkers in bladder cancer diagnosis and prognosis: From functional roles to clinical significance 2022 ·Frontiers in Oncology ·Nick Lee, (unknown), Mohit Bajaj, (unknown), (unknown), Joseph Bucci, Peter Graham, James Thompson, Jie Ni	21
11	Differentiation of renal masses with multi-parametric MRI: the de Silva St George classification scheme 2022 ·BMC Urology ·(unknown), (unknown), Peter Aslan, Peter Nash, Anthony Hutton, David Malouf, Dominic Lee, Paul Cozzi, Fiona Maclean, James Thompson	6
12	OA16.01 Plasma NGS At Time of Diagnostic Tissue Biopsy – Impact on Time to Treatment: Results From a Pilot Prospective Study 2021 ·Journal of Thoracic Oncology ·James Thompson, Charu Aggarwal, J. Wong, (unknown), (unknown), David M. DiBardino, (unknown), (unknown), Anthony R. Lanfranco, Edmund K. Moon, Andrew R. Haas, Anil Vachani, Erica L. Carpenter	2
13	The diagnostic utility of diffusion weighted MRI imaging and ADC ratio to distinguish benign from malignant renal masses: sorting the kittens from the tigers 2021 ·BMC Urology ·(unknown), (unknown), Peter Aslan, Peter Nash, Anthony Hutton, David Malouf, Dominic Lee, Paul Cozzi, Fiona Maclean, James Thompson	13
14	Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross‐sectional study of the additive diagnostic value of gallium‐68 prostate‐specific membrane antigen positron‐emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer 2020 ·British Journal of Urology ·Amer Amin, Alexandar Blazevski, James Thompson, Matthijs J. Scheltema, Michael S. Hofman, Declan G. Murphy, Nathan Lawrentschuk, Niranjan Sathianathen, Jada Kapoor, Henry H. Woo, Venu Chalasani, Krishan Rasiah, Pim J. van Leeuwen, Reuben Tang, Thomas W. Cusick, Phillip D. Stricker, Louise Emmett	45
15	<p>Quality Assessment and Comparison of Plasma-Derived Extracellular Vesicles Separated by Three Commercial Kits for Prostate Cancer Diagnosis</p> 2020 ·International Journal of Nanomedicine ·Bairen Pang, Ying Zhu, Jie Ni, Juanfang Ruan, James Thompson, David Malouf, Joseph Bucci, Peter Graham, Yong Li	26
16	Extracellular vesicles: the next generation of biomarkers for liquid biopsy-based prostate cancer diagnosis 2020 ·Theranostics ·Bairen Pang, Ying Zhu, Jie Ni, James Thompson, David Malouf, Joseph Bucci, Peter Graham, Yong Li	146
17	Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy 2018 ·World Journal of Urology ·Matthijs J. Scheltema, John Chang, Maret Böhm, Willemien van den Bos, Alexandar Blazevski, Ilan Gielchinsky, Anton M.F. Kalsbeek, Pim J. van Leeuwen, Tuan V. Nguyen, Theo M. de Reijke, Amila Siriwardana, James Thompson, Jean J. de la Rosette, Phillip D. Stricker	26
18	Learning Curves for Robotic Surgery: a Review of the Recent Literature 2017 ·Current Urology Reports ·Giorgio Mazzon, Ashwin Sridhar, (unknown), James Thompson, Senthil Nathan, T. Briggs, John D. Kelly, Greg Shaw	49
19	Effect of Intraoperative Electroacupuncture on Postoperative Pain, Analgesic Requirements, Nausea and Sedation: A Randomised Controlled Trial 2009 ·Acupuncture in Medicine ·(unknown), (unknown), James Thompson, (unknown)	26
20	Immunohistochemical detection of ornithine-decarboxylase in primary and metastatic human breast cancer specimens 2001 ·Breast Cancer Research and Treatment ·Andrea Manni, Stephanie H. Astrow, (unknown), James Thompson, David T. Mauger, Sharlene Washington	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact